BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright ©The Author(s) 2025.
World J Nephrol. Dec 25, 2025; 14(4): 110268
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.110268
Table 1 Baseline characteristics of included randomized controlled trial, mean ± SD
Ref.Total number of patientsNumber of patients in each group
Age
Gender (male/female)
BMI
Physical status (ASA I/II/III)
Type of PCA
ESPB
Control
ESPB
Control
ESPB
Control
ESPB
Control
ESPB
Control
Şahin et al[23], 202260303057.0 ± 6.553.8 ± 8.917/1316/1430.6 ± 4.927.6 ± 3.3N/AN/ATramadol
Xu et al[28], 2023166838366 ± 5.9363 ± 8.89
45/3838/4525 ± 3.7024 ± 2.969/58/167/62/14Sulfentanil
Özkalayci et al[24], 2023522527N/AN/AN/AN/AN/AN/AN/AN/AMorphine
Onay et al[26], 202340202060.95 ± 8.3855.15 ± 10.0814/1612/827.95 ± 4.0828.4 ± 4.520/16/41/15/4Morphine
Yang et al[25], 202450232352.08 ± 7.6550.3 ± 8.5914/911/1224.5 ± 3.1322.95 ± 2.782/20/11/21/1N/A
Atıcı et al[22], 202446202052.5 ± 9.3651.45 ± 9.3613/714/628.35 ± 1.6327.95 ± 3.306/14/05/15/0Morphine
Zhang et al[27], 2024110555553 ± 1153 ± 935/2028/2724.8 ± 3.324.6 ± 3.120/29/618/28/9Sufentanil
Özfırat et al[29], 202550252554.4 ± 12.152.4 ± 15.913/1212/1127.7± 3.726.4 ± 4.910/15/012/13/0Morphine
Loganathan et al[30], 202569343548 ± 1045 ± 108/264/31N/AN/A10/15/012/13/0Morphine
Table 2 Results using the risk of bias tool 2
Ref.
D1
D2
D3
D4
D5
Overall
Şahin et al[23], 2022++-++-
Xu et al[28], 2023++!+++
Özkalayci et al[24], 2023++++!+
Onay et al[26], 2023++!+++
Yang et al[25], 2024++++!+
Atıcı et al[22], 2024+++!++
Zhang et al[27], 2024++++++
Özfırat et al[29], 2025++++++
Loganathan et al[30], 2025++++++